IDiyas

For the Inventor, By the Inventor

Hopkinton, MA, United States of America

Keith P Wilson

USPTO Granted Patents = 28 

 

Average Co-Inventor Count = 5.7

ph-index = 11

Forward Citations = 322(Granted Patents)


Location History:

  • Brookline, MA (US) (2000)
  • Ft. Lauderdale, FL (US) (2004)
  • Boston, MA (US) (2002 - 2005)
  • La Jolla, CA (US) (2009)
  • San Diego, CA (US) (2013)
  • Hopkinton, MA (US) (1999 - 2014)

Company Filing History:

goldMedal26 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents
silverMedal1 out of 53 
 
Takeda San Diego, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1999-2014

Loading Chart...
Loading Chart...
28 patents (USPTO):
1. 8691848 - Inhibitors of caspases (2014-04-08),
2. 8618152 - Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases (2013-12-31),
3. 8338412 - Inhibitors of P38 (2012-12-25),
4. 8119631 - Inhibitors of interleukin-1β converting enzyme (2012-02-21),
5. 8002891 - Crystallization of C-Jun N-Terminal Kinase 3 (JNK3) (2011-08-23),
6. 7951809 - Inhibitors of p38 (2011-05-31),
7. 7790713 - Inhibitors of interleukin-1β converting enzyme (2010-09-07),
8. 7527952 - Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA) (2009-05-05),
9. 7507552 - Crystallization of histone deacetylase 2 (2009-03-24),
10. 7383135 - Methods of designing inhibitors for JNK kinases (2008-06-03),
11. 7365072 - Inhibitors of p38 (2008-04-29),
12. 7358273 - Inhibitors of caspases (2008-04-15),
13. 7216041 - Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket (2007-05-08),
14. 7205305 - Inhibitors of p38 (2007-04-17),
15. 7065452 - Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them (2006-06-20),

Title: Keith P Wilson: Advancing Innovations in Caspase and Protease Inhibitors

Introduction:

In the world of innovations and patents, Keith P Wilson, based in Hopkinton, MA (US), has made significant contributions as an inventor, researcher, and industry professional. With an impressive portfolio of 27 patents, Wilson has demonstrated his expertise in developing novel compounds and pharmaceutical compositions that target diverse diseases. This article delves into Wilson's latest patents, career highlights, and collaborations within the industry.

Latest Patents:

Wilson's recent patents showcase his focus on exploring new possibilities in the field of caspase and serine protease inhibitors. One of his notable inventions involves caspase inhibitors, specifically interleukin-1β converting enzyme (ICE) inhibitors. These compounds possess the potential to combat interleukin-1 (IL-1)-mediated diseases, autoimmune diseases, proliferative disorders, infectious diseases, and more. Wilson's pharmaceutical compositions offer promising alternatives for treating a range of challenging conditions.

Another significant patent by Wilson focuses on inhibitors of serine proteases, particularly hepatitis C virus NS3-NS4A proteases. These compounds interfere with the life cycle of the hepatitis C virus, thereby exhibiting antiviral properties. Such breakthrough inventions have the potential to revolutionize the treatment of HCV infections, offering new hope to patients worldwide.

Career Highlights:

Keith P Wilson's fruitful career includes tenure at esteemed companies, including Vertex Pharmaceuticals, Inc. and Takeda San Diego, Inc. While at these organizations, he leveraged his expertise and collaborative spirit to advance innovations in drug discovery and therapeutics.

Collaborations:

Wilson's impactful work in the field of innovations and patents has been amplified through his collaborations with fellow inventors, researchers, and industry professionals. Notably, he has collaborated with Guy W Bemis and Mark Andrew Murcko, both of whom share a passion for advancing scientific discoveries. Through these synergistic collaborations, Wilson has harnessed the power of collective intelligence to bring his ideas to fruition.

Conclusion:

Keith P Wilson's contributions to the realm of innovations, inventions, and patents have been truly commendable. With 27 patents to his name, including groundbreaking work in caspase and protease inhibitors, he has exhibited a knack for developing impactful solutions in the healthcare landscape. Wilson's collaborations and diverse career highlights are a testament to his dedication and passion for advancing scientific knowledge. As the world continues to face various medical challenges, Wilson's innovation-driven approach will undoubtedly foster significant advancements that benefit patients globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…